Page 19 - Haematologica May 2020

Editorials
ment possibilities available today. Often large datasets are collected over a long time with considerable changes in first-line therapy, such as introduction of pediatric-based regimens, while the number of patients in different cate- gories remains small. Considering the relative homogene- ity of transplant procedures in comparison to the different non-transplant protocols, the post-transplant CIBMTR score represents an important prognostic tool.
References
1. Nowell P, Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243(5405):290-293.
3. Rowley JD. Identificaton of a translocation with quinacrine fluores- cence in a patient with acute leukemia. Ann Genet. 1973. 1973;16(2):109-112.
4. Mrózek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev. 2004;18(2):115-136.
5. Rowe JM, Buck G, Burnett AK, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005;106(12):3760-3767.
6. Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424-447.
7. Mittelman F. The Third International Workshop on Chromosomes in Leukemia. Lund, Sweden, July 21-25, 1980. Introduction. Cancer Genet Cytogenet. 1981(4):96-98.
8. Roberts KG. Genetics and prognosis of ALL in children vs adults. Hematology Am Soc Hematol Educ Program. 2018;2018(1):137-145.
9. Moorman AV, Harrison CJ, Buck GAN, et al. Karyotype is an inde- pendent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative
Oncology Group (ECOG) 2993 trial. Blood. 2007;109(8):3189-3197.
10. Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of cytogenetics on the outcome of adult acute lymphoblastic
leukemia: results of Southwest Oncology Group 9400 study [eng].
Blood. 2008;111(5):2563-2572.
11. LazaryanA,DolanM,ZhangM-J,etal.Impactofcytogeneticabnor-
malities on outcomes of adult Philadelphia-negative acute lym- phoblastic leukemia after allogeneic hematopoietic stem cell trans- plantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research [eng]. Haematologica. 2020;105(5):1329-1338.
12. Aldoss I, Tsai N-C, Slovak ML, et al. Cytogenetics does not impact outcomes in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(7):1212-1217.
13. ShimizuH,DokiN,KanamoriH,etal.Prognosticimpactofcytoge- netic abnormalities in adult patients with Philadelphia chromosome- negative ALL who underwent an allogeneic transplant. Bone Marrow Transplant. 2019;54(12):2020-2026.
14. Lafage-Pochitaloff M, Baranger L, Hunault M, et al. Impact of cyto- genetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. 2017;130(16):1832-1844.
15. Niederwieser C, Nicolet D, Carroll AJ, et al. Chromosome abnor- malities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance). Haematologica. 2016;101(12):1516-1523.
16. DöhnerH,WeisdorfDJ,BloomfieldCD.Acutemyeloidleukemia.N Engl J Med. 2015;373(12):1136-1152.
17. Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytoge- netic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116(3):354-365.
18. ChenY,KantarjianH,PierceS,etal.Prognosticsignificanceof11q23 aberrations in adult acute myeloid leukemia and the role of allogene- ic stem cell transplantation. Leukemia. 2013;27(4):836-842.
19. Poiré X, Labopin M, Polge E, et al. The impact of concomitant cyto- genetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplanta- tion. Am J Hematol. 2020;95(3):282-294.
20. Inaba T, Honda H, Matsui H. The enigma of monosomy 7. Blood. 2018;131(26):2891-2898.
21. Shah MV, Jorgensen JL, Saliba RM, et al. Early post-transplant mini- mal residual disease assessment improves risk stratification in acute myeloid leukemia 7. Biol. Blood Marrow Transplant. 2018;24(7): 1514-1520.
haematologica | 2020; 105(5)
1179